FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today reported its financial results as of and for the three and twelve months ended December 31, 2009. For the three months ended December 31, 2009, the Company reported a net income of $1.1 million, or $0.05 per diluted share, compared to a net loss of $12.2 million, or $0.65 per diluted share, for the same period in 2008. For the twelve months ended December 31, 2009, the Company reported a net loss of $21.2 million, or $1.03 per diluted share, compared to a net loss of $8.0 million, or $0.43 per diluted share, for the same period in 2008. The Company ended the year with $75.1 million of cash and cash equivalents and investments.
